An ultra-rapid inhaled insulin that approximates glucose excursions following meals is a non-invasive, effective therapy for patients with type 1 or type 2 diabetes, according to research presented at the American Diabetes Association’s 74th Scientific Sessions.
Longtime type 1 PWD Dan Patrick, who joined us also at our 2013 DiabetesMine Innovation Summit, gives a great overview and evaluation of FRIO cooling packs for insulin storage. He’s a big fan!
So what was big coming out of ADA this year, from our POV? Here’s a smattering of key news, in no particular order.
We talk a lot about diabetes technology here in the abstract — but there’s no substitute for the real-world testimonials of the people living with this stuff attached to their bodies 24/7. Today our friend and fellow type 1 diabetes writer Dan Fleshler shares his very personal sentiments on wearing a CGM (continuous glucose monitor).
According to experts, patients under the age of 19 should try to maintain an A1C blood sugar level that’s less than 7.5 percent. A1C is a test that measures the average blood sugar (glucose) levels over the span of several months, according to a news release.
In two small clinical studies presented at a meeting of the American Diabetes Association in San Francisco on Sunday, researchers said patients with Type 1 diabetes were able to better control their blood sugar when using an insulin-pump system controlled by an algorithm, or mathematical formula, which was embedded in a smartphone application, than when […]
Health-care payers already spend more per member on diabetes medicine than for any other disease, and that spending is likely to grow substantially as the number of people diagnosed with the disease climbs from 366 million to 552 million by 2030.
The Lions Foundation of Canada Guide Dog program is the first official diabetes-related dog-training program introduced in Canada. Started in 2013, it currently is the only internationally-accredited program in the country. The dogs are trained by using samples of scents, says Natalie Moncur, communications manager at the Lions Foundation Guide Dogs of Canada.
Among diabetes patients receiving metformin, the addition of insulin compared with a sulfonylurea was associated with an increased risk of nonfatal cardiovascular outcomes and all-cause death
iHealth Lab, part of China-based Andon Health, has received FDA clearance and is launching its iHealth Align blood glucose monitor in the U.S. This is the smallest FDA cleared glucometer, but it requires an Android or iOS device to take readings.
“At its core, Lifebringer is a diabetic journal where you enter blood sugars and keep track of your health data. But what makes this different is that this free logging system has a nagging feature for those who need it — for those people who don’t want to stick their heads in the sand and […]
Many people with diabetes have switched to newer forms of insulin called analogs, because they can make the disease easier to manage. But that switch can be expensive, a study finds.
Hey Kids, last week Apple announced a new “HealthKit” for capturing health and fitness data, and one of their targets is supposedly diabetes care, which is very exciting — because who doesn’t want Apple to get involved in this stuff?!
Sugar is sugar. And honey is (mostly) sugar. But if you’re choosing between the two from a health perspective, err on the side of the sticky stuff.
Medtronic is launching in Europe the world’s first combined continuous glucose sensor and insulin infusion pump, the MiniMed Duo. This device will allow diabetics who have to be vigilant in controlling their glucose levels to use only one access point on their body for both monitoring and delivery of insulin.
Dexcom received FDA approval for Dexcom G4 PLATINUM Professional CGM, the first real-time continuous glucose monitor to be used by physicians for evaluating their patients’ blood sugar levels for up to seven days
A high-intensity sweetener developed by Japanese food and chemical corporation, Ajinomoto, Advantame is about 20,000 times sweeter than sucrose
The combination product is the first to contain “a basal insulin with an ultralong duration of action, and a rapid-acting insulin in a single injection. The researchers conducted an open label study of 447 people with diabetes.
Lifebringer is a free, interactive web-based app for type 1 and 2 diabetics, as well as newly diagnosed diabetics, that goes beyond simply tracking blood sugars and organizing numbers input users. It also uses Meehan’s program, called Nagbot, to interact with the user.
Medtronic is leading the charge on new diabetes devices again, with a first-of-its-kind combo device launched in Europe that brings a continuous glucose monitoring (CGM) sensor and insulin infusion set together into a single device with combined insertion capability!